SCHEMBL539142

SCHEMBL539142

CCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 11/20 0.66
SLC6A5 Q9Y345 2/20 0.57
EPHX2 P34913 3/20 0.55
GLP1R P43220 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11102825 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL19499060 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2340732 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL4277325 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2341081 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2341993 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2341089 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL4278821 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL11102827 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2344383 1.00 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 633 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629468-B2 Devices and methods for delivering synergistic active agents to target sites IRRIMAX Corporation (US) 2026-05-19 US claimed
CN-122037184-A Polyamide acid solution, preparation method thereof and polyimide film 中国石油天然气股份有限公司 2026-05-15 CN claimed
EP-4333804-B1 IN-SITU FILM-FORMING COMPOSITION LABORATORIOS INIBSA S A (ES) 2025-12-17 EP claimed
EP-3528776-B1 REDUCED-ETHANOL MOUTH RINSE FORMULATIONS KENVUE BRANDS LLC (US) 2025-11-26 EP claimed
EP-3986371-B1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOL HENKEL AG & CO KGAA (DE) 2025-08-20 EP claimed
US-20250213777-A1 DEVICES AND METHODS FOR DELIVERING SYNERGISTIC ACTIVE AGENTS TO TARGET SITES IRRIMAX Corporation 2025-07-03 US claimed
US-20240415743-A1 SHAMPOO IN SOLID FORM TO BE RECONSTITUTED IN AN AQUEOUS ENVIRONMENT LES SOLUTIONS ZERO DECHET FILLGOOD INC. (CA) 2024-12-19 US claimed
CN-118853305-A New energy automobile space purifying agent and preparation method and application thereof 广东月福汽车用品有限公司 2024-10-29 CN claimed
US-20240226369-A1 IN-SITU FILM-FORMING COMPOSITION LABORATORIOS INIBSA, S.A. (ES) 2024-07-11 US claimed
WO-2024065055-A1 CONDITIONING FORMULA IN POWDER FORM LES SOLUTIONS ZERO DECHET FILLGOOD INC. (CA) 2024-04-04 WO claimed
WO-2011029077-A2 BOTANICAL EXTRACTS AND FLAVOR SYSTEMS AND METHODS OF MAKING AND USING THE SAME SENSIENT FLAVORS LLC (US) 2011-03-10 WO claimed
US-20110059205-A1 BOTANICAL EXTRACTS AND FLAVOR SYSTEMS AND METHODS OF MAKING AND USING THE SAME SENSIENT FLAVORS LLC 2011-03-10 US claimed
EP-1635774-B2 STABLE DENTIFRICE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2011-01-26 EP claimed
EP-1635774-B1 STABLE DENTIFRICE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2007-08-08 EP claimed
CN-1471904-A Cosmetics composition 味之素株式会社 2004-02-04 CN claimed
US-20030124156-A1 Cosmetic composition AJINOMOTO CO., INC. (JP) 2003-07-03 US claimed
CN-1083712-C Solid foam composition formed from a natural product OREAL (FR) 2002-05-01 CN claimed
CN-1185730-A Solid foam composition formed from a natural product OREAL (FR) 1998-06-24 CN claimed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP claimed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629468-B2 Devices and methods for delivering synergistic active agents to target sites ARG1, ASS1, TLR1 NOD1 948/4885SLC6A5 1122/4885EPHX2 2140/4885
US-20030124156-A1 Cosmetic composition CUTA, PARG, PARN NOD1 4865/4885SLC6A5 4093/4885EPHX2 3477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.